Nasdaq: DNTH
Dianthus Therapeutics insiders
The officers, directors and 10% owners of Dianthus Therapeutics, Inc. who hold the most stock, valued at the live DNTH price.
$84.83
DNTH today +$850K (+1.01%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 4
- Their DNTH stock
- $467M
- Market value
- $4.78B
- Held by ranked insiders
- 9.78%
Insiders by value of DNTH holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Trv GP Iv, LLC | 10% owner | 3,058,204 | $259M | 5.43% | Corporate |
| 2 | Leon O. Moulder Jr. | Director | 1,436,745 | $122M | 2.55% | 1169th |
| 3 | Jason Gardner | See Remarks | 944,954 | $80.2M | 1.68% | 1789th |
| 4 | Marino Garcia | CEO AND PRESIDENT | 65,292 | $5.5M | 0.12% | 13487th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Dianthus Therapeutics; see each profile for the filing.